Loading…

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution

Saved in:

Bibliographic Details
Published in:	Leukemia 2015-06, Vol.29 (6), p.1435-1437
Main Authors:	Puig, N, Conde, I, Jiménez, C, Sarasquete, M E, Balanzategui, A, Alcoceba, M, Quintero, J, Chillón, M C, Sebastián, E, Corral, R, Marín, L, Gutiérrez, N C, Mateos, M-V, González-Díaz, M, San-Miguel, J F, García-Sanz, R
Format:	Article
Language:	English
Subjects:	45 45/23 631/67/68 692/420/755 Cancer Research Clonal Evolution Complementarity Determining Regions - genetics Complementarity-determining region 3 Critical Care Medicine Development and progression Disease Progression Genetic aspects Health aspects Hematology Humans Identification and classification Immunoglobulin Heavy Chains - genetics Immunoglobulins Intensive Internal Medicine letter-to-the-editor Medicine Medicine & Public Health Multiple myeloma Multiple Myeloma - diagnosis Multiple Myeloma - genetics Myeloma Oncogenes Oncology Time Factors
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!